Diphtheria, Tetanus, and Pertussis Immunity in Indian Adults and Immunogenicity of Td Vaccine

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td align="left">Antigen</td><td align="center"></td><td align="center">Prevaccination</td><td align="center">Post-vaccination</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td align="left" rowspan="2">Diphtheria</td><td align="center">Long-term seroprotection</td><td align="center">8.62 (3.74–18.64)</td><td align="center">87.93 (76.6–95.1)</td></tr><tr><td align="center">GMT (IU/mL)</td><td align="center">0.36 (0.28–0.47)</td><td align="center">2.17 (1.66–2.83)</td></tr><tr><td align="left" rowspan="2">Tetanus</td><td align="center">Long-term seroprotection</td><td align="center">74.14 (60.9–84.8)</td><td align="center">96.55 (87.9–99.7)</td></tr><tr><td align="center">GMT (IU/mL)</td><td align="center">1.13 (1.01–1.27)</td><td align="center">2.79 (2.21–3.52)</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td>
              *All figures in parenthesis for Long-term seroprotection as well as GMT contains 95% CI.<br/></td></tr></table>

Comparison of long-term seroprotection and GMT with 95% CI.

International Scholarly Research Notices

tab1

Table 1

Table 1: Diphtheria, Tetanus, and Pertussis Immunity in Indian Adults and Immunogenicity of Td Vaccine 